These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6696045)

  • 41. Enhancing effect of barbital on N-2-fluorenylacetamide-induced rat liver lesions.
    Mori H; Tanaka T; Nishikawa A; Takahashi M; Williams GM
    Gan; 1981 Oct; 72(5):798-801. PubMed ID: 7327380
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Redifferentiation as a basis for remodeling of carcinogen-induced hepatocyte nodules to normal appearing liver.
    Tatematsu M; Nagamine Y; Farber E
    Cancer Res; 1983 Nov; 43(11):5049-58. PubMed ID: 6137276
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Phenotypic characterization of metaplastic intestinal glands and ductular hepatocytes in cholangiofibrotic lesions rapidly induced in the caudate liver lobe of rats treated with furan.
    Elmore LW; Sirica AE
    Cancer Res; 1991 Oct; 51(20):5752-9. PubMed ID: 1655260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Modulation of Fas-FasL related apoptosis by PBN in the early phases of choline deficient diet-mediated hepatocarcinogenesis in rats.
    Inoue Y; Asanuma T; Smith N; Saunders D; Oblander J; Kotake Y; Floyd RA; Towner RA
    Free Radic Res; 2007 Sep; 41(9):972-80. PubMed ID: 17729114
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Complementarity between two rat liver tumor promoters.
    Laconi E; Vasudevan S; Rao PM; Rajalakshmi S; Sarma DS
    Toxicol Pathol; 1987; 15(2):198-201. PubMed ID: 2887030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Abnormalities in liver iron accumulation during N-2-fluorenylacetamide hepatocarcinogenesis that are dependent or independent of continued carcinogen action.
    Furuya K; Maeura Y; Williams GM
    Toxicol Pathol; 1984; 12(2):136-42. PubMed ID: 11478314
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Origin and structural evolution of the early proliferating oval cells in rat liver.
    Paku S; Schnur J; Nagy P; Thorgeirsson SS
    Am J Pathol; 2001 Apr; 158(4):1313-23. PubMed ID: 11290549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Light and electron microscopic studies of diet-induced hepatic changes in mice.
    Degertekin H; Akdamar K; Yates R; Chen IL; Ertan A; Vaupel R
    Acta Anat (Basel); 1986; 125(3):174-9. PubMed ID: 3962578
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of alpha-fetoprotein- and albumin-containing cells in the livers of Fischer rats fed four cycles of N-2-fluorenylacetamide.
    Sell S
    Cancer Res; 1978 Sep; 38(9):3107-13. PubMed ID: 79445
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sex steroid hormones levels and testicular activity during hepatocarcinogenesis by N-2-fluorenylacetamide.
    Lafaurie M; Aussel C; Castelli D; Krebs B; Stora C
    Res Commun Chem Pathol Pharmacol; 1982 Jul; 37(1):49-63. PubMed ID: 6181546
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Enhanced survival and absence of progressive growth of transplanted rat liver altered eosinophilic foci and neoplastic nodules in phenobarbital-treated rats.
    Mori H; Furuya K; Williams GM
    J Natl Cancer Inst; 1983 Oct; 71(4):849-54. PubMed ID: 6194334
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modulation of hepatic mRNA translation activity and specific expression of arylsulfotransferase IV during acetylaminofluorene-induced rat hepatocarcinogenesis.
    Yerokun T; Norton TR; Howell B; Ringer DP
    Cancer Res; 1991 Jan; 51(2):504-9. PubMed ID: 1670761
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Resistance to the cytocidal effects of adriamycin is an early phenotypic change induced during hepatocarcinogenesis.
    Carr BI; Laishes BA
    Br J Cancer; 1981 Oct; 44(4):567-71. PubMed ID: 7295513
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Light and electron microscopic analysis of liver sinusoids during hepatocarcinogenesis with 2-acetylaminofluorene in rats.
    Shoji Y; Kaneda K; Wake K; Mishima Y
    Jpn J Cancer Res; 1994 May; 85(5):491-8. PubMed ID: 8014107
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of phenacetin and N-alkylacetanilides on N-2-fluorenylacetamide hepatocarcinogenesis.
    Yamamoto RS; Frankel HH; Weisburger EK
    Cancer Lett; 1979 Dec; 8(2):183-8. PubMed ID: 555875
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Short-term induction of neoplastic nodules in the rat liver. II. Study of their development and the effects of withdrawal of 2-acetylaminofluorene.
    van der Heijden CA; Dormans JA
    Carcinogenesis; 1981; 2(2):147-56. PubMed ID: 7273298
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoelectron microscopy identification of early proliferating cells in rat liver tissue during hyperplasia induced by lead nitrate.
    Rijhsinghani K; Choi HS; Burton LA; Paronetto F; Tavoloni N
    Hepatology; 1993 Apr; 17(4):685-92. PubMed ID: 8477973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A liver colony assay for a new hepatocyte phenotype as a step toward purifying new cellular phenotypes that arise during hepatocarcinogenesis.
    Laishes BA; Fink L; Carr BI
    Ann N Y Acad Sci; 1980; 349():373-82. PubMed ID: 6939366
    [No Abstract]   [Full Text] [Related]  

  • 59. Choline deficiency selects for resistance to p53-independent apoptosis and causes tumorigenic transformation of rat hepatocytes.
    Zeisel SH; Albright CD; Shin OH; Mar MH; Salganik RI; da Costa KA
    Carcinogenesis; 1997 Apr; 18(4):731-8. PubMed ID: 9111207
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Morphology of early changes in liver carcinogenesis induced by methapyrilene.
    Reznik-Schüller HM; Lijinsky W
    Arch Toxicol; 1981 Nov; 49(1):79-83. PubMed ID: 7325803
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.